Bio-Techne (TECH) Cash from Operations (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16% |
| Dec 31, 2025 | 198.75% |
| Sep 30, 2025 | -71.91% |
| Jun 30, 2025 | 138.82% |
| Mar 31, 2025 | -51.25% |
| Dec 31, 2024 | 32.02% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -6.78% |
| Mar 31, 2024 | -2.56% |
| Dec 31, 2023 | 39.97% |
| Sep 30, 2023 | -28.79% |
| Jun 30, 2023 | 65.02% |
| Mar 31, 2023 | -21.51% |
| Dec 31, 2022 | 14.81% |
| Sep 30, 2022 | -45.40% |
| Jun 30, 2022 | 40.46% |
| Mar 31, 2022 | -27.59% |
| Dec 31, 2021 | 108.52% |
| Sep 30, 2021 | -60.31% |
| Jun 30, 2021 | 62.98% |
| Mar 31, 2021 | -16.13% |
| Dec 31, 2020 | 35.24% |
| Sep 30, 2020 | 47.37% |
| Jun 30, 2020 | -9.46% |
| Mar 31, 2020 | -29.75% |
| Dec 31, 2019 | 73.70% |
| Sep 30, 2019 | -27.54% |
| Jun 30, 2019 | 41.06% |
| Mar 31, 2019 | -14.82% |
| Dec 31, 2018 | 18.04% |
| Sep 30, 2018 | -39.16% |
| Jun 30, 2018 | 199.49% |
| Mar 31, 2018 | -44.75% |
| Dec 31, 2017 | -12.34% |
| Sep 30, 2017 | -12.10% |
| Jun 30, 2017 | 103.23% |
| Mar 31, 2017 | -39.90% |
| Dec 31, 2016 | 57.08% |
| Sep 30, 2016 | -27.69% |
| Jun 30, 2016 | -1.32% |
| Mar 31, 2016 | -3.64% |
| Dec 31, 2015 | 21.07% |
| Sep 30, 2015 | -14.29% |
| Jun 30, 2015 | 20.68% |
| Mar 31, 2015 | -13.86% |
| Dec 31, 2014 | 0.02% |
| Sep 30, 2014 | -5.81% |
| Jun 30, 2014 | 8.55% |
| Mar 31, 2014 | 11.53% |
| Dec 31, 2013 | -3.88% |
| Sep 30, 2013 | 8.66% |
| Jun 30, 2013 | -9.20% |
| Mar 31, 2013 | 5.56% |
| Dec 31, 2012 | 6.92% |
| Sep 30, 2012 | -21.78% |
| Jun 30, 2012 | 8.56% |
| Mar 31, 2012 | 68.62% |
| Dec 31, 2011 | -40.64% |
| Sep 30, 2011 | -0.69% |
| Jun 30, 2011 | 7.06% |
| Mar 31, 2011 | 10.03% |
| Dec 31, 2010 | -4.14% |
| Sep 30, 2010 | -3.39% |
| Jun 30, 2010 | 36.88% |
| Mar 31, 2010 | -17.76% |
| Dec 31, 2009 | 0.73% |